PRESENTATION

The Graduate Program in biotechnology and Innovation in Health presents a coordinated structure for the development of innovative biotech products in the health area, propitiating the teachers and researchers’  formation trained to meet the new technological demands of our country. Following what is  recommended by the policy of  biotechnology development in Brazil, which seeks to promote  consistent and long-term  public policies to make it possible for the exploitation of the opportunities and potential of Brazil in the field of biotechnology, the courses of Academic Master's and  Doctor’s degree  in biotechnology and Innovation in Health  offer proposals for scientific and formative quality   that present themselves as an approximation of the academic knowledge with the productive sector in the biotechnology area  in Brazil, strategic need for the country's future. The courses of Academic Master's and Doctor’s  programs were approved by  CAPES in May 2012, both with grade  4. The program had its beginning with notice and selective process classifying in September 2012 the doctor’ and master’s degree candidates.

 

Structure

The Biotechnology and Innovation in Health Program  presents a coordinated structure for the development of innovative biotech products in the health area, showing a balance between the number of teachers that sustain the inter-related  research lines, the distribution of developed projects and participation in the offered  subjects.


Goals

The  program objectives of biotechnology and Innovation in Health are: prepare the  students to research, teaching and scientific-technological activity of innovation with emphasis on interdisciplinarity represented in order to integrate the technological areas with those of health. The future  trained and qualified professionals to operate in the professional market, will mainly operate in research centers, higher education institutions, in the industrial sector, in  Sistema Único de Saúde. This proposal is based on the need to supply a priority area of supplying professionals facing the development of biotechnological products. In addition, due to the importance of the specialized training of graduate student in biotechnology, coming from differentiated and multidisciplinary characteristic of the group of teachers who compose the Program, stimulate the creation and transfer of technology, in a continuous manner, taking as its focus the incorporation of new products by the productive sector. In this context, the university occupies its space as an element in the forefront of technological innovation, with insertion in the regional and national economies, by the ability to develop education and transfer the results of research of high scientific and technological standard. It should be noted, therefore, that the proposal for this program is to strengthen the importance of the development of integrated research for the  human resources training  in the biotechnology area. The professional profile  to be formed are masters and doctors with critical spirit and ethical  and scientific reflection that contribute not only to the knowledge (that is linear and disciplinary), but also to  innovation (that is emerging and transdisciplinary).


Target Audience

Professionals from the areas of Biotechnology, Biomedicine, Biology, Pharmacy, Medicine, Veterinary Medicine, Dentistry, Chemistry and related areas, subject to the approval of the collegiate body of the program.

CONCENTRATION AREA

Biotechnology

The concentration  area of  Biotechnology and Innovation in Health is characterized by conducting studies and research aimed at answering the needs of related areas located in the university/industry/ health  interface, complying with  the country's priority demands in the biotechnology area. This interface is based on the current concept of convergent science , characterized by the junction of several strands of knowledge that build their cognitive universe and underpin their fundamental bases in the interdisciplinarity of knowledge important for the  applicability of  results. In this context, the concentration area of Biotechnology and Innovation in Health reflects the growing need of future professionals to develop new technologies using knowledge acquired in traditional areas such as biochemistry, pharmacology, molecular biology, physical-chemical, dentistry, phytotherapy and bioinformatics, in the direction of obtaining methods and innovative biotech products and in the characterization of its mechanisms of action. The study of biocompatibility, biomechanics, biochemistry and pre-clinical and clinical aspects of bioactive inputs will converge to support the choice of the biotechnology area. The research projects represented by this concentration area  have as objectives the synthesis, isolation and the development of bioactive inputs, the investigation of their properties, interactions with the tissues and organic environments, the studies of modulation of gene expression in genomic, proteomic, epigenetic approaches and pre-clinical and clinical  assessment of the same, and also the validation and certification of experimental research protocols, which are fundamental to support the development of new bioactive inputs.

 

Research Lines

Bioactive Inputs  and Nanotechnology in Health - Line 1

This research  line has as objectives: Isolate bioactive materials of natural origin, derived from plants and resinous substance secreted by animals (ex. propolis), employing different extraction techniques; identify and quantify the isolated active principles  by means of gas chromatography with the use of markers and mass spectrometry; investigate and develop synthetic methodologies for obtaining new bioactive compounds through organic and inorganic synthesis; use these methodologies of synthesis to improve the physicochemical properties of molecules with interest of biological applications; apply  nanotechnology to the development of devices and synthesis of functional materials, through the matter control at the nanometer scale, so that the resulting systems present new phenomena and potential properties in the development of Pharmaceutical formulations and use in dentistry, such properties are dependent on the particles  size  that constitute  the same; to establish a correlation among  the properties presented   by each of the classes of produced biomaterials and their applicability; to evaluate the physicochemical biomaterials properties  by means of studies involving spectroscopic , morphological, diffraction techniques, among others.



Molecular and Cellular Biology Applied to Health - Line 2

This line seeks to address the basic concepts of cellular, and molecular biology, biochemistry, biotechnology, bioengineering, bioinformatics, mechanisms of pathogenicity, the use of molecular markers in diagnostics and studies with adult stem cells, aiming to upgrade the student on themes of technological application that use biological systems, living organisms, or derivatives thereof, to produce products and processes. The studies linked to this research  line will emphasize the strategic issues in current Biotechnology policy such, as recombinant DNA technology for obtaining therapeutic molecules in heterologous expression systems; updates on application of biotechnological processes for industrial production, nanobiotechnology, new systems of "drug-delivery", tissue engineering , biomaterials interaction  in cell and tissue culture, genomics, proteomics and bioinformatics, expanding and updating the knowledge about production and applicability of biotechnology in the health area. The research in this line have as a guideline  the integration of the scientific production and the applicability in the development of products and processes arising out of the same, responding to the country’s  needs  in the integration of obtaining new targets and to use for diagnosis and treatment in the health area,  differential obtained by biotechnology.


Pre-clinical and Clinical Studies of Biotechnological Products - Line 3

This research line aims to evaluate pre-clinical and clinical, bioactive  inputs, in their different phases. The studies regarding this line of research include studies of biological, pharmacological, physiological, biochemical, biophysical and dental  processes as well as its multidisciplinary interaction contributing to the evaluation and development of innovative therapeutic products and processes in the health technology area, their  safety and efficacy, with obedience to the ethical standards. Implementation of intervention studies organized in preclinical and clinical assays with the goal of generating knowledge and  proving e the performance of biotechnological products in their clinical application. It also aims at the assessment of research protocols already established, as well as the evaluation of new protocols.

SELECTION AND ENROLLMENTS

CURRICULAR STRUCTURE

Mandatory  Subjects

  • Research Methodology, Bioethics and Biosafety
  • Cellular and Molecular  Biology
  • Management and Entrepreneurship (Required only for Doctor’s degree  programs)

 

General optional subjects

  • Teaching methodology and Teaching Traineeship
  • Biostatistics
  • Intellectual property and Patents
  • Public Policies in Health
  • Special topics in Biotechnology

 

Specific Subjects Regarding the Research Lines:
 

  1. Development of biotechnological products; Analytical Methods Applied to biotechnology; Nanotechnology
  2. Advanced Seminars in Biotechnology; Tissue Engineering and Biocompatibility; Molecular mechanisms of pathogenicity; Models of biological evaluation
  3. Fundamentals of Clinical Research; Preclinical evaluation of biotechnological products; Clinical Applied  Research

 

FACULTY MEMBERS

PERMANENTES

Profa. Dra. Alejandra Hortência Miranda González
E-mail: alejandra.horten@anhanguera.com  
Latteshttp://lattes.cnpq.br/1059436387901853

 

Prof. Dr. José Agustín Pablo Quincoces Suárez
E-mail: jose_suarez@anhanguera.com
Lattes: http://lattes.cnpq.br/4626630514277737

 

Profa. Dra. Julia Alejandra Pezuk 
E-mail: julia.pezuk@anhanguera.com
Latteshttp://lattes.cnpq.br/8670465117564774

 

Prof. Dra. Marcela Rocha de Oliveira Carrilho
E-mail: marcelacarrilho@anhanguera.com
Lattes: http://lattes.cnpq.br/4743117509008232

 

Profa. Dra. Maria Cristina Marcucci Ribeiro
E-mail: cristina.marcucci@anhanguera.com
Lattes: http://lattes.cnpq.br/3785872046836692

 

Prof. Dr. Paulo Henrique Perlatti D’Alpino 
E-mail: paulodalpino@anhanguera.com
Lattes: http://lattes.cnpq.br/3631978345125809

 

Profa. Dra. Regina Mara Silva Pereira
E-mail: reginapereira1@anhanguera.com
Lattes: http://lattes.cnpq.br/2466263512645770

 

Profa. Dra. Simone dos Santos Grecco
E-mail: grecco.ssimone@anhanguera.com
Lattes: http://lattes.cnpq.br/2381333302640138

 

Profa. Dra. Susana Nogueira Diniz
E-mail: susana.diniz@anhanguera.com
Lattes: http://lattes.cnpq.br/4054631406346707

 

Profa. Dra. Waleska Kerllen Martins Gardesani
E-mail: wkerllenmartins@gmail.com
Lattes: http://lattes.cnpq.br/8877675145336750

CONTACT

DOCUMENTS

Aditamento Nº 012/2018

Aditamento Nº 011/2018

Aditamento Nº 009/2018 - Doutorado

Aditamento Nº 008/2018 - Mestrado

Edital de Resultado - 2018/2 - Doutorado

Edital de Resultado - 2018/2 - Mestrado

EDITAL Nº 016/2018 - PROCESSO SELETIVO - 2018/2 Doutorado

EDITAL Nº 014/2018 - PROCESSO SELETIVO - 2018/2 - Mestrado

EDITAL Nº 011/2018 - PROCESSO SELETIVO PROSUP

EDITAL Nº. 008/2018 - PROSUP/CAPES - Biotecnologia

Resultado Processo Seletivo 2018 - Doutorado

Resultado Processo Seletivo 2018 - Mestrado

Edital de Resultado - PNPD

Edital 010/2017 - Processo Seletivo Doutorado 2018/1

Edital 009/2017 - Processo Seletivo Mestrado 2018/1

Edital Nº008/2017 - Pós-Doutorado

Aditamento nº003/2017

Edital Resultado - PNPD

Edital Nº006/2017 - Resultado

Lista de Deferimento / Indeferimento

Aditamento Nº.002/2017 - Processo Seletivo

Aditamento Nº.001/2017 - PNPD Biotecnologia e Inovação em Saúde

Edital 004/2017 - Processo Seletivo Mestrado em Biotecnologia e Inovação em Saúde

Edital 003/2017 - Processo Seletivo para PNPD

Edital PROSUP 002/17 - Resultado

Edital Bolsas PROSUP - 2017/1